These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20946148)

  • 41. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.
    Souto JC; Almasy L; Soria JM; Buil A; Stone W; Lathrop M; Blangero J; Fontcuberta J
    Thromb Haemost; 2003 Mar; 89(3):468-74. PubMed ID: 12624629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism.
    Berger M; Moscatelli H; Kulle B; Luxembourg B; Blouin K; Spannagl M; Lindhoff-Last E; Schambeck CM
    Thromb Haemost; 2008 May; 99(5):905-8. PubMed ID: 18449420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.
    Herrera-Rivero M; Stoll M; Hegenbarth JC; Rühle F; Limperger V; Junker R; Franke A; Hoffmann P; Shneyder M; Stach M; Nowak-Göttl U
    Thromb Haemost; 2021 Sep; 121(9):1169-1180. PubMed ID: 33592630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.
    Desch KC; Ozel AB; Siemieniak D; Kalish Y; Shavit JA; Thornburg CD; Sharathkumar AA; McHugh CP; Laurie CC; Crenshaw A; Mirel DB; Kim Y; Cropp CD; Molloy AM; Kirke PN; Bailey-Wilson JE; Wilson AF; Mills JL; Scott JM; Brody LC; Li JZ; Ginsburg D
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):588-93. PubMed ID: 23267103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.
    Karakaya B; Tombak A; Serin MS; Tiftik N
    Hematology; 2016 Jun; 21(5):295-9. PubMed ID: 26872106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
    Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
    Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
    Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of unique venous thromboembolism-susceptibility variants in African-Americans.
    Heit JA; Armasu SM; McCauley BM; Kullo IJ; Sicotte H; Pathak J; Chute CG; Gottesman O; Bottinger EP; Denny JC; Roden DM; Li R; Ritchie MD; de Andrade M
    Thromb Haemost; 2017 Apr; 117(4):758-768. PubMed ID: 28203683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke.
    Williams SR; Hsu FC; Keene KL; Chen WM; Dzhivhuho G; Rowles JL; Southerland AM; Furie KL; Rich SS; Worrall BB; Sale MM;
    Stroke; 2017 Jun; 48(6):1444-1450. PubMed ID: 28495826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients.
    Paiva SG; Sabino AP; Carvalho MG; Ribeiro DD; Gomes KB; Santos MS; Oliveira MS; Lages GG; Dusse LM; Fernandes AP
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):122-8. PubMed ID: 19786939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study.
    James PD; Paterson AD; Notley C; Cameron C; Hegadorn C; Tinlin S; Brown C; O'Brien L; Leggo J; Lillicrap D;
    J Thromb Haemost; 2006 Apr; 4(4):783-92. PubMed ID: 16634747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
    Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
    J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
    Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
    J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.
    Edvardsen MS; Hindberg K; Hansen ES; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood Adv; 2021 Jan; 5(1):224-232. PubMed ID: 33570640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.